Tilray Inc. ($TLRY) Stock Forecast: Down 5.0% Today

What is Tilray Inc.?

Tilray Brands Inc. (TLRY) operates in the cannabis industry, specializing in various cannabis products and beverages, and experienced a significant decline in its stock price today.

Why is Tilray Inc. going down?

TLRY stock is down 5.0% on Mar 27, 2026 17:42

• Concerns arose among investors over Tilray's decision to enter the alcoholic ready-to-drink beverages market through a licensing agreement with The Magnum Ice Cream Company.
• The upcoming quarterly earnings report, along with predictions of a potential EPS loss despite revenue growth from new beverage products, contributed to the negative market sentiment.
• The general market downturn, as evidenced by declines in the NASDAQ Composite Index and the Dow Jones Industrial Average, influenced the selling pressure on Tilray stock.
• Despite recent positive developments such as new partnerships and product launches, Tilray's stock struggled to surpass key moving averages, and conflicting analyst opinions may have fueled the downward trajectory.

TLRY Price Chart

TLRY Technical Analysis

TLRY News

Tilray strikes RTD licence deal with The Magnum Ice Cream Company

Tilray Brands has signed a licensing agreement with The Magnum Ice Cream Company to launch a new line of Popsicle-branded alcoholic ready-to-drink (RTD) beverages. This expansion aims to give an "adult upgrade" to classic Popsicle flavors, with the first wave of 5% abv hard malt beverages launching this month in major US retailers. This move follows Tilray's recent deals with Carlsberg for brewing and distribution and the acquisition of BrewDog assets.

https://www.just-drinks.com/news/tilray-rtd-licence-deal-the-magnum-ice-cream-company/

Tilray Brands (TLRY) Expected to Announce Quarterly Earnings on Wednesday

Tilray Brands (TLRY) is scheduled to release its Q3 2026 results before the market opens on Wednesday, April 1st, with analysts predicting a loss of ($0.14) EPS on $201.35 million in revenue. The company recently announced a licensing deal for Popsicle® Hard ready-to-drink beverages, which could boost beverage revenue. Despite topping estimates last quarter, the stock is currently trading below its 50- and 200-day moving averages, and consensus remains a "Hold."

https://www.marketbeat.com/instant-alerts/tilray-brands-tlry-expected-to-announce-quarterly-earnings-on-wednesday-2026-03-27/

Tilray Brands, Inc. (TLRY) Falls Further Than the Market: What Investors Should Know

Tilray Brands (TLRY) shares recently fell by 5.76%, underperforming the broader market and the Medical sector over the last month. Investors are anticipating the company's upcoming earnings report on April 1, 2026, with analysts forecasting an improved EPS but a significant decline in full fiscal year earnings. Tilray currently holds a Zacks Rank of #3 (Hold), influenced by recent upward revisions in analyst estimates.

https://www.bitget.com/amp/news/detail/12560605308598

Selling pressure pushes Tilray stock lower in today's trading

Tilray Brands, Inc. (TLRY) experienced a 3.96% drop in its stock price, closing at $6.67 amid strong selling pressure and high intraday volatility. The stock remains below key moving averages, indicating a persistent downtrend despite recent positive developments like new product launches and expanded partnerships. Analysts have mixed views, with some seeing continued downside risk if current support levels break, and others highlighting underlying strengths that could lead to future growth.

https://tradersunion.com/news/financial-news/show/1804087-tilray-slides-3-96percent-today-to/

Tilray Brands Inc. stock falls Thursday, underperforms market

Tilray Brands Inc. (TLRY) shares fell 5.76% to $6.54 on Thursday, ending a three-day winning streak. This decline occurred during a challenging trading session for the broader market, with the NASDAQ Composite Index down 2.38% and the Dow Jones Industrial Average down 1.01%.

https://www.marketwatch.com/data-news/tilray-brands-inc-stock-falls-thursday-underperforms-market-3e61e183-2683cf3265af?gaa_at=eafs&gaa_n=AWEtsqfufX3pVVFTC-Ymxj0UsyIdo4o7AFSJt8gR44Nby_tNnoyTpdCXPu9P&gaa_ts=69c6a108&gaa_sig=uEyZRRYwmJGdKTLFni-1CW2ehwcKha6v223UhHKYer7vHkkcIQLU4VqTdJj8jCNaZkm_cZdnITcfUFnnAI84Iw%3D%3D

Trending Today

Dogecoin ($DOGE) Crypto Forecast: Up 5.3% Today

Paycom Software Inc. ($PAYC) Stock Forecast: Down 5.1% Today

Entergy Corporation ($ETR) Stock Forecast: Up 7.0% Today

Crowdstrike Holdings Inc. ($CRWD) Stock Forecast: Down 5.7% Today

Crude Oil ($CRUDE) Commodity Forecast: Up 6.2% Today

Norwegian Cruise Line Holdings Ltd. ($NCLH) Stock Forecast: Down 6.5% Today

Align Technology Inc. ($ALGN) Stock Forecast: Down 6.1% Today

Carnival Corporation ($CCL) Stock Forecast: Down 5.6% Today

Brent Crude Oil ($BRENT) Commodity Forecast: Up 5.0% Today

Avis Budget Group Inc. ($CAR) Stock Forecast: Up 5.4% Today

Tilray Inc. Price History

10.02.2026 - TLRY Stock was up 6.9%

• TLRY's bullish movement can be attributed to its strategic acquisition of BrewDog's Australian assets, including the Brisbane brewery and a network of bars, to expand its presence in the Asia-Pacific region.
• The expansion into Australia serves as a gateway for Tilray to introduce its broader beverage portfolio to new markets, enhancing its global beverage revenues.
• This move not only strengthens Tilray's international brewing footprint but also positions the company to capitalize on the growing demand for craft beverages in the Asia-Pacific market, driving investor optimism and contributing to the bullish market movement of TLRY.

24.01.2026 - TLRY Stock was up 5.3%

• Despite a new exclusive licensing deal for beer distribution in the U.S. with Carlsberg, Tilray's stock continues to struggle, reflecting ongoing financial difficulties and consistent share price decline.
• The company's active acquisition strategy and continual cash consumption have led to a decrease in shareholder value, prompting analysts to recommend exploring other investment options.
• Despite a slight decrease in Tilray's stock value during a bullish market period, investors are eagerly awaiting the upcoming earnings report, hoping for positive growth in both earnings per share and revenue for the quarter.
• The exclusive U.S. licensing agreement with Carlsberg aims to enhance Tilray's presence in the beverage market but market sentiment remains cautious due to the company's historical performance and limited growth prospects.

20.02.2026 - TLRY Stock was down 5.4%

• Acquired BrewDog's US assets to expand alcohol beverage portfolio did not have a positive impact on stock price.
• Despite expanding medical cannabis portfolio in Australia, introducing new products did not prevent bearish trend.
• Underperformance compared to broader market and sector, along with anticipation of negative earnings per share in upcoming report, likely led to bearish movement.
• Consecutive days of losses amidst challenging trading session for overall market emphasized bearish sentiment surrounding the stock.

19.01.2026 - TLRY Stock was up 5.8%

• Tilray's stock experienced a strong bullish movement of over 4% following the announcement of the exclusive brewing and licensing agreement with Carlsberg Group.
• The partnership with Carlsberg is expected to bring immediate scale and revenue to Tilray, driving optimism among investors and leading to the bullish market movement.
• This strategic move aligns with Tilray's focus on partnering with established brands and maximizing its beverage operations, showcasing a promising future for the company in the competitive beer market.
• The market's positive reaction reflects investor confidence in Tilray's ability to leverage its operational infrastructure effectively and strengthen its position in the premium European segment of the US beer market.

26.02.2026 - TLRY Stock was down 5.2%

• Concerns arose among investors due to Tilray's partnership with Popsicle to launch "Popsicle Hard" beverages, potentially affecting its core business focus.
• The anticipation of Tilray's third-quarter fiscal year 2026 financial results on April 1, 2026, could be causing uncertainty and volatility in the stock.
• Investor caution regarding the financial results may lead to a sell-off of Tilray stock in expectation of disappointing earnings or guidance.
• The absence of specific positive updates or catalysts may be contributing to the bearish sentiment surrounding Tilray's stock today.

05.01.2026 - TLRY Stock was down 6.6%

• The acknowledgment of Tilray Pharma's CC Pharma as a TOP 100 Innovator in Germany underlines the company's dedication to innovation and operational excellence within the pharmaceutical distribution industry.
• Notwithstanding this positive development, the decrease in Tilray Brands shares could be linked to profit-taking by investors following a recent uptrend or broader market uncertainties impacting the stock price.
• The forthcoming nationwide promotional campaign in Tilray's U.S. craft beer taprooms might have shifted investor attention away from the pharmaceutical sector, resulting in a temporary decline in the stock price.
• Investors may be anticipating the upcoming financial update in early April to evaluate the company's overall performance and growth trajectory, possibly influencing the bearish sentiment surrounding the stock today.

25.02.2026 - TLRY Stock was up 6.6%

• The increase in Tilray's stock price is likely the result of oversold conditions, leading to short-term optimism among investors.
• Anticipation for the upcoming third fiscal quarter results scheduled for April 1, 2026, has contributed to positive market sentiment.
• Despite facing profitability challenges with a negative net margin, recent company activities such as acquiring BrewDog U.S. assets and expanding medical cannabis partnerships have bolstered investor confidence.
• Analyst opinions on the stock vary, with a consensus "Hold" rating; however, the temporary rebound suggests that investors are cautiously positive about Tilray's future prospects.

25.02.2026 - TLRY Stock was up 8.2%

• TLRY stock rose by 3.57% to $6.68 today, following recent bearish trends, despite trading below significant moving averages.
• The stock's uptick may be linked to oversold conditions identified by certain technical indicators, attracting short-term investors seeking opportunities.
• Uncertainty over U.S. federal cannabis rescheduling discussions continues to impact investor sentiment, contributing to the stock's volatility.
• TLRY's recent acquisition of craft brewer BrewDog and CEO Irwin Simon's plans to revitalize the brand through expansion efforts may have also influenced the positive market movement, highlighting the company's commitment to diversification and growth strategies.

05.02.2026 - TLRY Stock was down 5.2%

• The purchase of BrewDog brand and assets may have sparked initial investor interest, but the subsequent stock decline suggests concerns over deal execution or financial impacts.
• Despite expansions in product lines and partnerships, overall market sentiment and uncertainties about the upcoming earnings report likely contributed to TLRY's bearish movement.
• Good Supply's introduction of high-THC products could have provided a small boost, but the limited availability and regional exclusivity may not have been enough to counter broader market pressures.
• TLRY's stock outperformance in the last month despite sector challenges highlights investor scrutiny, particularly with the upcoming earnings report shaping market sentiments.

18.01.2026 - TLRY Stock was up 5.5%

• An analyst has given TLRY a Hold rating and set a price target of C$13, expressing concerns about the beer market and optimism regarding potential US legislation impact.
• Despite falling short of Q4 earnings projections and recording a negative net margin, Zacks Research upgraded its rating on TLRY from "strong sell" to "hold."
• A recent partnership with Smartway Pharmaceuticals to enhance the distribution of medical cannabis products in the UK has been seen as a strategic move that likely boosted investor confidence and contributed to positive stock movement.
• Institutional investors making changes to their holdings by either increasing or starting new positions in TLRY may have helped drive the stock price upwards.

27.02.2026 - TLRY Stock was down 5.0%

• Concerns arose among investors over Tilray's decision to enter the alcoholic ready-to-drink beverages market through a licensing agreement with The Magnum Ice Cream Company.
• The upcoming quarterly earnings report, along with predictions of a potential EPS loss despite revenue growth from new beverage products, contributed to the negative market sentiment.
• The general market downturn, as evidenced by declines in the NASDAQ Composite Index and the Dow Jones Industrial Average, influenced the selling pressure on Tilray stock.
• Despite recent positive developments such as new partnerships and product launches, Tilray's stock struggled to surpass key moving averages, and conflicting analyst opinions may have fueled the downward trajectory.

10.01.2026 - TLRY Stock was up 5.2%

• Tilray's stock showed a robust 1.6% bullish movement today, disregarding recent downgrades and cautious analyst views.
• Q2 FY2026 saw the company achieving record net revenue due to growth in international medical cannabis sales and Canadian adult-use cannabis. This demonstrates its ability to navigate market fluctuations.
• The company's expansion of its U.S. beverage alcohol division and recognition of its German medical distribution subsidiary showcase strategic efforts to diversify revenue sources and bolster presence in key markets.
• Notwithstanding challenges like missed earnings estimates and negative net margin, Tilray's dual focus on medical cannabis and spirits sectors, along with international expansion, appears to have positively impacted investor sentiment and influenced today's bullish movement.